-
IMV to progress clinical development of Covid-19 vaccine
pharmaceutical-technology
March 20, 2020
IMV has initiated plans to progress the clinical development of a Covid-19 vaccine candidate, to determine the clinical safety and immunogenicity.
-
Vaccine development key to beating outbreak, says Zhong
chinadaily
March 19, 2020
The COVID-19 pandemic cannot be controlled by the herd immunity strategy and vaccines will be the key to ultimately tackling the virus, said Zhong Nanshan, a prominent Chinese expert in respiratory diseases.
-
Moderna Leads Coronavirus Vaccine Charge
contractpharma
March 19, 2020
First participant dosed in NIH-led Phase 1 study of mRNA vaccine against novel coronavirus.
-
CEPI calls for $2bn of funding for coronavirus vaccine
europeanpharmaceuticalreview
March 18, 2020
According to CEPI, $2 billion is needed to progress coronavirus vaccines through development as quickly as possible, leading the organisation to call for donations.
-
BioNTech signs Covid-19 vaccine deals with Pfizer and Fosun
pharmaceutical-technology
March 18, 2020
German biotechnology firm BioNTech has partnered with Pfizer to jointly develop and distribute a potential mRNA-based Covid-19 vaccine.
-
First US clinical trial of Covid-19 vaccine candidate begins
pharmaceutical-technology
March 18, 2020
The first US clinical trial of a Covid-19 vaccine candidate, which is Moderna’s mRNA-1273, has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.
-
Pfizer, BioNTech to co-develop potential coronavirus vaccine
expresspharma
March 18, 2020
US drugmaker Pfizer has signed a deal with Germany’s BioNTech to co-develop a potential vaccine for the coronavirus using BioNTech’s mRNA-based drug development platform.
-
First Patient Dosed in Moderna's COVID-19 Vaccine Trial
biospace
March 17, 2020
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 began.
-
BioNTech teams up with Fosun Pharma to test Covid-19 mRNA vaccine in China — and scores $50M investment
endpts
March 17, 2020
Having quietly launched its own mRNA vaccine efforts against the novel coronavirus to match the higher profile campaigns of Moderna and CureVac ...
-
EMA offers free advice to COVID-19 vaccine and therapeutic developers
europeanpharmaceuticalreview
March 17, 2020
The European Medicines Agency (EMA) announced it will provide free advice to those working on COVID-19 therapeutics and vaccines in the hopes of accelerating approval of a treatment.